ShockWave Medical, Inc.
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Douglas E. Godshall
- Full Time Employees
- 1,468
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- 5403 Betsy Ross Drive Santa Clara CA United States of America 95054
- IPO Date
- Mar 7, 2019
- CIK
- 0001642545
- Website
- shockwavemedical.com
- Similar Companies
- Business
- ShockWave Medical, Inc. is a medical device company specializing in the development, manufacture, and commercialization of intravascular lithotripsy (IVL) technology used to treat calcified cardiovascular disease. Its core products include the ShockWave IVL platform and catheters, which deliver pulsatile sonic pressure waves to fracture vascular calcium, facilitating the expansion of arteries during balloon angioplasty procedures. These products are primarily employed in the treatment of coronary and peripheral artery diseases. The company serves a broad range of healthcare providers and operates globally, with a focus on expanding usage in both the U.S. and international markets. Founded in 2009 and headquartered in Santa Clara, California, ShockWave Medical operates within the medical technology industry, particularly in the cardiovascular interventional segment. The company’s IVL system is recognized for its distinctive approach to treating calcified lesions, positioning ShockWave Medical as an innovator in minimally invasive cardiovascular therapies. In the last 1-2 years, ShockWave Medical has notably expanded its commercial footprint and product offerings. This includes strategic partnerships to enhance distribution capabilities, introduction of next-generation IVL catheters with improved design features, and efforts to broaden clinical indications for its technology. The company has also engaged in funding initiatives and collaborative alliances aimed at accelerating product adoption and advancing clinical research. These developments reflect a strategic emphasis on increasing market penetration and addressing unmet needs in calcified vessel treatments. ShockWave Medical markets its products primarily to hospitals, cardiovascular specialists, and healthcare systems, aiming to improve procedural outcomes for patients with calcified coronary and peripheral artery disease. It maintains its headquarters in Santa Clara, California, and supports operations across North America, Europe, and selected international regions through its subsidiaries and partners. This comprehensive profile highlights ShockWave Medical's specialized medical device offerings, recent strategic advancements, and its commitment to innovation within cardiovascular disease treatment.
Rubicon Point Partners Acquires Shockwave Medical Headquarters Campus in Santa Clara, California
Sarepta Therapeutics Set to Join S&P MidCap 400
Charles Schwab Investment Management Inc. Grows Position in Shockwave Medical, Inc. (NASDAQ:SWAV)
J&J's $13 billion bid for Shockwave turns to Wall Street for funding
SHOCKWAVE MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Shockwave Medical, Inc. - SWAV
Shockwave Medical (SWAV) Q1 Earnings Beat, Revenues Rise Y/Y
Shockwave Medical (SWAV) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Shockwave Medical (SWAV) Q1 Earnings and Revenues Top Estimates
Shockwave Medical Reports First Quarter 2024 Financial Results
Shockwave Medical (SWAV) Earnings Expected to Grow: What to Know Ahead of Q1 Release
Why the Market Dipped But Shockwave Medical (SWAV) Gained Today
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Shockwave Medical (SWAV) Advances While Market Declines: Some Information for Investors
Why Shockwave Medical (SWAV) Could Beat Earnings Estimates Again
Top 5 Non-Tech Nasdaq Winners of Q1 With More Upside Left
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SWAV, AIRC, INRD
INVESTIGATION: The M&A Class Action Firm Announces an Investigation of Shockwave Medical, Inc. - SWAV
Shockwave Medical's (SWAV) Reducer Receives Positive Results
SHOCKWAVE MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Shockwave Medical, Inc. - SWAV
Shockwave Reducer Demonstrates Consistent, Positive Results in ‘Real-World' Study